The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder.
作者信息
Garel Nicolas, Greenway Kyle, Joober Ridha
机构信息
From McGill University, Psychiatry residency program (Garel, Greenway); and McGill University, Douglas Mental Health University Institute, (Joober), Montreal, Que., Canada.
出版信息
J Psychiatry Neurosci. 2021 Jan 18;46(1):E164-E165. doi: 10.1503/jpn.200114.
Abstract
摘要
相似文献
1
The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder.大麻二酚的抗精神病潜力：对患有精神病和合并大麻使用障碍患者的临床意义。
J Psychiatry Neurosci. 2021 Jan 18;46(1):E164-E165. doi: 10.1503/jpn.200114.
2
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.大麻使用者首发精神病患者采用大麻二酚治疗的潜力。
Schizophr Bull. 2018 Jan 13;44(1):46-53. doi: 10.1093/schbul/sbx105.
3
Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series.药用大麻（Bedrolite）替代疗法治疗伴有合并症的精神病住院患者和大麻使用障碍：病例系列。
J Psychopharmacol. 2018 Mar;32(3):353-356. doi: 10.1177/0269881117735684. Epub 2017 Oct 17.
4
Cannabis Use Among Patients With Psychotic Disorders.精神障碍患者的大麻使用情况。
Perm J. 2021 May 12;25:20.179. doi: 10.7812/TPP/20.179.
5
Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals.阿立哌唑用于治疗超高风险个体的大麻所致精神病性症状。
Clin Neuropharmacol. 2013 May-Jun;36(3):98-9. doi: 10.1097/WNF.0b013e3182908330.
6
Medical use of cannabis. Cannabidiol: a new light for schizophrenia?医用大麻。大麻二酚：精神分裂症的新曙光？
Drug Test Anal. 2013 Jan;5(1):46-51. doi: 10.1002/dta.1425. Epub 2012 Oct 25.
7
Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.精神分裂症患者合并 cannabis 使用治疗失败：系统综述。
Psychiatry Res. 2019 Oct;280:112523. doi: 10.1016/j.psychres.2019.112523. Epub 2019 Aug 17.
8
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.精神分裂症谱系障碍伴与不伴大麻依赖的精神药理学比较。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):212-7. doi: 10.1016/j.pnpbp.2010.11.007. Epub 2010 Nov 16.
9
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.大麻对精神分裂症或分裂情感性障碍患者出院抗精神病药物剂量影响的研究。
Psychiatr Q. 2016 Dec;87(4):729-737. doi: 10.1007/s11126-016-9426-2.
10
Cannabidiol modulation of hippocampal glutamate in early psychosis.大麻二酚对早期精神病中海马谷氨酸的调节作用。
J Psychopharmacol. 2021 Jul;35(7):814-822. doi: 10.1177/02698811211001107. Epub 2021 Apr 16.
本文引用的文献
1
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials.在癫痫治疗中使用大麻二酚：临床试验的疗效和安全性。
Molecules. 2019 Apr 12;24(8):1459. doi: 10.3390/molecules24081459.
2
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.大麻二酚（CBD）作为精神分裂症的辅助治疗：一项多中心随机对照试验。
Am J Psychiatry. 2018 Mar 1;175(3):225-231. doi: 10.1176/appi.ajp.2017.17030325. Epub 2017 Dec 15.
3
Can we make cannabis safer?我们能让大麻更安全吗？
Lancet Psychiatry. 2017 Aug;4(8):643-648. doi: 10.1016/S2215-0366(17)30075-5. Epub 2017 Mar 2.
4
Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered.心理社会干预在减少早期精神病患者大麻使用方面的作用：一项关于加拿大所提供治疗方法的调查。
Can J Psychiatry. 2016 Jun;61(6):367-72. doi: 10.1177/0706743716639931. Epub 2016 Mar 16.
5
Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study.首次发作精神病中大麻使用与住院及抗精神病治疗失败的关联：一项观察性研究。
BMJ Open. 2016 Mar 3;6(3):e009888. doi: 10.1136/bmjopen-2015-009888.
6
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.大麻素与精神分裂症：风险与治疗潜力
Neurotherapeutics. 2015 Oct;12(4):816-24. doi: 10.1007/s13311-015-0382-6.
7
Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use.首发精神病患者中使用大麻的情况：患病率、开始使用及持续使用时间进程的荟萃分析
Aust N Z J Psychiatry. 2016 Mar;50(3):208-19. doi: 10.1177/0004867415599846. Epub 2015 Aug 18.
8
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.大麻二酚：药理学及在癫痫和其他神经精神疾病中的潜在治疗作用。
Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22.
9
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.大麻二酚增强了内源性大麻素信号传导，并缓解了精神分裂症的精神病症状。
Transl Psychiatry. 2012 Mar 20;2(3):e94. doi: 10.1038/tp.2012.15.
10
Cannabidiol for the treatment of psychosis in Parkinson's disease.大麻二酚治疗帕金森病精神病。
J Psychopharmacol. 2009 Nov;23(8):979-83. doi: 10.1177/0269881108096519. Epub 2008 Sep 18.
Zotero 插件